09/15/2023
4:35 PM | Abbott Laboratories (Issuer)
Funck, Jr. Robert E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2023
5:48 PM | Abbott Laboratories (Issuer)
MCCOY JOHN A. JR. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/06/2023
5:50 PM | Abbott Laboratories (Issuer)
MCCOY JOHN A. JR. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2023
5:53 PM | Abbott Laboratories (Issuer)
Boudreau Philip P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/01/2023
3:13 PM | Abbott Laboratories (Filer)
| Form 8-K/A | |
08/10/2023
5:31 PM | Abbott Laboratories (Issuer)
Wainer Andrea F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/28/2023
4:10 PM | Abbott Laboratories (Issuer)
STARKS DANIEL J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
07/20/2023
7:29 AM | Abbott Laboratories (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/05/2023
10:54 AM | Abbott Laboratories (Issuer)
Alpern Robert J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2023
10:55 AM | Abbott Laboratories (Issuer)
Morrone Louis H. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2023
10:56 AM | Abbott Laboratories (Issuer)
Gonzalez Patricia Paola (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2023
10:57 AM | Abbott Laboratories (Issuer)
Roman Michael F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2023
10:57 AM | Abbott Laboratories (Issuer)
Stratton John G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
3:07 PM | Abbott Laboratories (Filer)
| Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d) | |
06/20/2023
5:55 PM | Abbott Laboratories (Issuer)
Boudreau Philip P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
2:18 PM | Abbott Laboratories (Subject)
Boudreau Philip P (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/12/2023
9:32 AM | Abbott Laboratories (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/03/2023
6:09 PM | Abbott Laboratories (Issuer)
Wainer Andrea F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2023
5:13 AM | Abbott Laboratories (Filer)
| Form S-3ASR | |
05/02/2023
6:57 PM | Abbott Laboratories (Issuer)
McKinstry Nancy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2023
6:59 PM | Abbott Laboratories (Issuer)
O'Grady Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2023
7:02 PM | Abbott Laboratories (Issuer)
Roman Michael F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2023
7:04 PM | Abbott Laboratories (Issuer)
STARKS DANIEL J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2023
7:08 PM | Abbott Laboratories (Issuer)
Stratton John G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2023
6:51 PM | Abbott Laboratories (Issuer)
Gonzalez Patricia Paola (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2023
6:53 PM | Abbott Laboratories (Issuer)
Kumbier Michelle (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2023
6:55 PM | Abbott Laboratories (Issuer)
McDew Darren W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2023
6:33 PM | Abbott Laboratories (Issuer)
O'Grady Michael (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/02/2023
6:34 PM | Abbott Laboratories (Subject)
MANNING JOSEPH J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/02/2023
6:37 PM | Abbott Laboratories (Issuer)
Alpern Robert J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2023
6:39 PM | Abbott Laboratories (Issuer)
Babineaux-Fontenot Claire (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2023
6:42 PM | Abbott Laboratories (Issuer)
Blount Sally E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2023
6:01 PM | Abbott Laboratories (Subject)
Wainer Andrea F (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/02/2023
6:26 PM | Abbott Laboratories (Subject)
WOODGRIFT RANDEL WILLIAM (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/02/2023
2:25 PM | Abbott Laboratories (Subject)
STARKS DANIEL J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/02/2023
5:00 AM | Abbott Laboratories (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/19/2023
6:25 AM | Abbott Laboratories (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/10/2023
10:53 AM | Abbott Laboratories (Subject)
Canadian Shareholder Association for Research & Education (Filed by)
| Form PX14A6G | |
04/04/2023
6:25 PM | Abbott Laboratories (Issuer)
Alpern Robert J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2023
6:27 PM | Abbott Laboratories (Issuer)
Gonzalez Patricia Paola (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2023
6:29 PM | Abbott Laboratories (Issuer)
Roman Michael F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
04/04/2023
6:32 PM | Abbott Laboratories (Issuer)
Stratton John G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/02/2023
6:43 PM | Abbott Laboratories (Issuer)
Mateus Fernando (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/02/2023
6:45 PM | Abbott Laboratories (Issuer)
Moreland Mary K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/02/2023
6:47 PM | Abbott Laboratories (Issuer)
Morrone Louis H. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/02/2023
6:49 PM | Abbott Laboratories (Issuer)
PEDERSON MICHAEL J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/02/2023
6:52 PM | Abbott Laboratories (Issuer)
Salvadori Daniel Gesua Sive (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/02/2023
6:55 PM | Abbott Laboratories (Issuer)
Tyler Julie L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/02/2023
6:27 PM | Abbott Laboratories (Issuer)
Earnhardt Lisa D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/02/2023
6:30 PM | Abbott Laboratories (Issuer)
Ford Robert B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/02/2023
6:35 PM | Abbott Laboratories (Issuer)
Funck, Jr. Robert E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/02/2023
6:36 PM | Abbott Laboratories (Issuer)
Ginascol John F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/02/2023
6:38 PM | Abbott Laboratories (Issuer)
Karam Sammy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/02/2023
6:40 PM | Abbott Laboratories (Issuer)
MANNING JOSEPH J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/02/2023
6:16 PM | Abbott Laboratories (Issuer)
ALLEN HUBERT L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/02/2023
6:19 PM | Abbott Laboratories (Issuer)
Boudreau Philip P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/02/2023
6:22 PM | Abbott Laboratories (Issuer)
Calamari Christopher J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/02/2023
6:23 PM | Abbott Laboratories (Issuer)
CAPEK JOHN M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/02/2023
6:25 PM | Abbott Laboratories (Issuer)
DALE MICHAEL D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/02/2023
6:13 PM | Abbott Laboratories (Issuer)
Ahlberg Gregory A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2023
6:29 PM | Abbott Laboratories (Issuer)
WOODGRIFT RANDEL WILLIAM (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2023
5:58 PM | Abbott Laboratories (Issuer)
Karam Sammy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2023
6:00 PM | Abbott Laboratories (Issuer)
MANNING JOSEPH J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2023
6:03 PM | Abbott Laboratories (Issuer)
Mateus Fernando (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2023
6:14 PM | Abbott Laboratories (Issuer)
Moreland Mary K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2023
6:16 PM | Abbott Laboratories (Issuer)
Morrone Louis H. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2023
6:18 PM | Abbott Laboratories (Issuer)
Salvadori Daniel Gesua Sive (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2023
6:20 PM | Abbott Laboratories (Issuer)
Tyler Julie L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2023
6:22 PM | Abbott Laboratories (Issuer)
Wainer Andrea F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2023
6:24 PM | Abbott Laboratories (Issuer)
Watkin Jared (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2023
6:25 PM | Abbott Laboratories (Issuer)
Wellisch Alejandro D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2023
5:48 PM | Abbott Laboratories (Issuer)
Earnhardt Lisa D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2023
5:50 PM | Abbott Laboratories (Issuer)
Ford Robert B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2023
5:53 PM | Abbott Laboratories (Issuer)
Funck, Jr. Robert E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2023
5:56 PM | Abbott Laboratories (Issuer)
Ginascol John F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2023
5:37 PM | Abbott Laboratories (Issuer)
ALLEN HUBERT L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2023
5:38 PM | Abbott Laboratories (Issuer)
Boudreau Philip P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2023
5:40 PM | Abbott Laboratories (Issuer)
Calamari Christopher J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2023
5:43 PM | Abbott Laboratories (Issuer)
CAPEK JOHN M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2023
5:46 PM | Abbott Laboratories (Issuer)
DALE MICHAEL D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2023
5:34 PM | Abbott Laboratories (Issuer)
Ahlberg Gregory A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/09/2023
9:54 AM | Abbott Laboratories (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
02/06/2023
3:35 PM | Abbott Laboratories (Subject)
BlackRock Inc. (Filed by)
| Form SC 13G/A | |
01/25/2023
6:38 AM | Abbott Laboratories (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2023
5:13 PM | Abbott Laboratories (Issuer)
Gonzalez Patricia Paola (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2023
5:15 PM | Abbott Laboratories (Issuer)
Roman Michael F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2023
5:17 PM | Abbott Laboratories (Issuer)
Stratton John G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2023
5:09 PM | Abbott Laboratories (Issuer)
Alpern Robert J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2023
4:32 PM | Abbott Laboratories (Issuer)
Karam Sammy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/15/2022
4:26 PM | Abbott Laboratories (Issuer)
Ginascol John F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2022
3:06 PM | Abbott Laboratories (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
|
10/31/2022
4:44 PM | Abbott Laboratories (Issuer)
STARKS DANIEL J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/21/2022
3:05 PM | Abbott Laboratories (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/19/2022
6:58 AM | Abbott Laboratories (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2022
4:24 PM | Abbott Laboratories (Issuer)
Gonzalez Patricia Paola (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2022
4:26 PM | Abbott Laboratories (Issuer)
Roman Michael F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2022
4:27 PM | Abbott Laboratories (Issuer)
Stratton John G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2022
4:30 PM | Abbott Laboratories (Issuer)
Ahlberg Gregory A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
